© 2023 MJH Life Sciences and Oncology Nursing News. All rights reserved.
© 2023 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
July 03, 2017
The indication for the DigniCap Cooling System has been expanded by the FDA to include alopecia reduction across all solid tumors.
May 30, 2017
Patients treated with cisplatin-based chemotherapy had a higher risk of venous thromboembolism.
April 19, 2017
An ongoing trial is evaluating the addition of PARP inhibitor velaparib to a chemotherapy combination, for patients with HER2-negative, germline BRCA-associated metastatic or locally advanced breast cancer.
March 27, 2017
An ongoing trial is evaluating the combination therapy of interleukin-10 agonist AM0010 and FOLFOX chemotherapy, for patients with metastatic pancreatic cancer.
March 23, 2017
For patients with BRCA+ ovarian cancer, olaparib in the maintenance setting has shown impressive progression free survival benefits.
March 15, 2017
According to a recent survey, the main causes for a lack of HPV vaccine uptake are a lack of knowledge and a failure by healthcare providers to recommend it.
January 19, 2017
The FDA has granted accelerated approval of ibrutinib for treatment of marginal zone lymphona (MZL).
December 20, 2016
A recent survey indicates that many patients with MPNs experience a high symptom burden that affects their emotional wellbeing, quality of life, and functionality.
November 01, 2016
In a recent phase III study, the PARP-inhibitor olaparib was shown to improve progression-free survival for patients with BRCA-positive ovarian cancer.
October 25, 2016
An update on CDK4 and CDK6 inhibitors in treatment for patients with metastatic breast cancer.